Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE
Author:
Affiliation:
1. Department of Radiotherapy, Gansu Tumor Hospital, 730050 Lanzhou, Gansu, China
2. Gynecologic Oncology Department, Gansu Tumor Hospital, 730050 Lanzhou, Gansu, China
Abstract
Funder
Research Institute of Medical Sciences hospital list of items in Gansu Province
Publisher
Hindawi Limited
Subject
Health Informatics,Biomedical Engineering,Surgery,Biotechnology
Link
http://downloads.hindawi.com/journals/jhe/2021/8556965.pdf
Reference20 articles.
1. SREBP2 contributes to cisplatin resistance in ovarian cancer cells
2. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
3. Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea
4. Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule
5. Potent Anti-Tumor Effect Generated by a Novel Human Papillomavirus (HPV) Antagonist Peptide Reactivating the pRb/E2F Pathway
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long Noncoding RNAs in Ovarian Cancer—Functions and Clinical Applications;Frontiers in Bioscience-Landmark;2023-04-06
2. Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma;Molecular Therapy - Oncolytics;2023-03
3. Radiation induced therapeutic effects in cancerous and tumor cells: A review;Journal of Stem Cell Research & Therapeutics;2023-02-02
4. Retracted: Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE;Journal of Healthcare Engineering;2022-11-24
5. Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology;Journal of Personalized Medicine;2022-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3